Robinson Value Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$1.06M Buy
+15,701
New +$1.03M 1.01% 38
2018
Q3
$1.25M Sell
16,142
-4,529
-22% -$342K 1.15% 38
2018
Q2
$1.46M Sell
20,671
-748
-3% -$52.8K 1.33% 30
2018
Q1
$1.61M Sell
21,419
-373
-2% -$29.7K 1.49% 28
2017
Q4
$1.56M Sell
21,792
-690
-3% -$52.4K 1.37% 32
2017
Q3
$1.82M Buy
22,482
+1,070
+5% +$81.8K 1.67% 29
2017
Q2
$1.52M Buy
21,412
+440
+2% +$29.3K 1.42% 34
2017
Q1
$1.42M Sell
20,972
-441
-2% -$31K 1.32% 32
2016
Q4
$1.53M Buy
+21,413
New +$1.59M 1.44% 29

Other funds holding GILD

Robinson Value Management's GILD Position: Q2 2019 in Review

Robinson Value Management opened a new position in Gilead Sciences (GILD) in Q2 2019: 15,701 shares worth $1.06M. The stake represents 1.01% of the portfolio and ranks #38 among its holdings. This is a return to the name: Robinson Value Management previously reported a position in GILD as recently as Q3 2018.

Robinson Value Management first reported a position in GILD in Q4 2016 and has held it in 9 quarters since. The position peaked at $1.82M in Q3 2017. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Robinson Value Management held 15,701 shares of Gilead Sciences worth $1.06M as of Q2 2019.
  • Gilead Sciences was a new Robinson Value Management position in Q2 2019.
  • Gilead Sciences made up 1.01% of Robinson Value Management's portfolio in Q2 2019, its #38 holding.
  • Robinson Value Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 9 quarters since.
  • Robinson Value Management's Gilead Sciences position peaked at $1.82M in Q3 2017.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Robinson Value Management's 13F filing for Q2 2019, filed 12 Aug 2019.